Related Experiment Video
Updated: Jun 13, 2026

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
Published on: December 3, 2019
[LDL-cholesterol levels in a series of HIV-infected patients]
Marisa Gallego1, Rosario Palacios, Julián Olalla
1Hospital Virgen de la Victoria, Málaga, España.
Insights
Over 20% of HIV patients did not meet their LDL-cholesterol (LDL-C) goals. Central obesity and longer antiretroviral therapy increased risk, highlighting the need for better lipid management in this population.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Context:
- HIV-infected patients often have dyslipidemia.
- Cardiovascular disease is a leading cause of mortality in HIV patients.
- Current guidelines recommend specific LDL-cholesterol (LDL-C) targets based on cardiovascular risk factors.
Purpose:
- To determine the prevalence of patients with human immunodeficiency virus (HIV) who do not achieve their target LDL-cholesterol (LDL-C) levels.
- To identify factors associated with failure to reach LDL-C goals in this population.
Summary:
- A cross-sectional study of 1019 HIV-infected patients found that 22.8% did not reach their target LDL-C levels.
- Higher LDL-C levels were associated with obesity (OR=1.98), longer duration of antiretroviral therapy (OR=1.92 per 2 years), and stricter LDL-C targets (OR=16.9 for Groups B/C).
- Central obesity and time on antiretroviral therapy were significant factors associated with elevated LDL-C.
Impact:
- Findings indicate a significant unmet need for lipid management in HIV-infected individuals.
- Identifying risk factors can help tailor interventions to prevent cardiovascular events.
- This study underscores the importance of monitoring and managing LDL-C in HIV patients to reduce cardiovascular risk.
Background And Objective:
To analyse the prevalence of HIV-infected patients who do not reach their target LDL-cholesterol (LDL-C) levels.
Patients And Methods:
Multicenter, cross-sectional study of all HIV-infected patients on regular follow-up in 5 hospitals in the province of Malaga (March-August/07). They were classified depending on their target LDL-C levels (NCEP): group A:<160mg/dl, if =1 cardiovascular risk factor (CVRF); group B: <130mg/dl, if >/=2 CVRF; group C: <100mg/dl, if cardiovascular disease or equivalents or CVR at 10 years >20%). A comparison between patients reaching their target LDL-C levels and those not reaching them was done. Statistic program: SPSS.
Results:
Of 1019 included patients, 232 (22.8%) did not reach their target LDL-C levels. There were 693 patients in Group A, 163 in Group B, and 153 in Group C (6.6%, 53.3 % and 65.0% respectively (p<0.05)) who did not reach their target LDL-C. Factors associated with LDL-C levels higher than target were: obesity (OR=1.98; 95%CI: 1.14-3.46; p=0.01), time on antiretroviral therapy (for each 2 years OR=1.92; 95%CI: 1.85-1.99; p=0.02), and being included in Groups B and C (OR=16.9; 95%CI: 10.8-26.6; p=0.00001).
Conclusions:
More than 20% of the patients in this cohort did not reach their target LDL-C levels. Factors associated with high LDL-C levels were central obesity, time on antiretroviral therapy and being included in Groups B and C.
More Related Videos
Related Concept Videos
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Cholesterol: Significance and Regulation
Considering cholesterol and...

